35.172.217.174
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Cornea and External Disease

Should CXL be performed on early-stage patients with keratoconus?

Posted on March 18, 2021
Should CXL be performed on early-stage patients with keratoconus?

The vision‐related quality of life of patients with early keratoconus remains high but sharply declines after disease progression and does not improve after corneal cross‐linking, according to a study.

In this combined prospective/cross‐sectional study, 56 patients with keratoconus took the Refractive Status and Vision Profile (RSVP) and the National Eye Institute Visual Functioning – 25 (NEI‐25) questionnaires. Overall, 26 patients had stable disease and 30 had progressive; 10 patients had undergone corneal cross‐linking.

A minor decline in vision‐related quality of life was found in patients with early keratoconus was found whereas patients with progressive keratoconus demonstrated a statistically significant decline, which did not improve after corneal cross‐linking.

The researchers concluded that the current strategy to perform corneal cross‐linking only after progression in patients with keratoconus should be re-evaluated.

Reference
Steinberg J, Bußmann N, Frings A, et al. Quality of life in stable and progressive ‘early‐stage’ keratoconus patients. Acta Ophthalmol. 2021;99:e196-e201.

-Advertisement-
Related Articles
FDA approves Verkazia for treatment of vernal keratoconjunctivitis
Jun 24, 2021
Adjuvant cross-linking doesn’t appear beneficial for bacterial keratitis
Jun 14, 2021
Study compares 3 intrastromal injections for recalcitrant fungal keratitis
Jun 14, 2021
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-